Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy

Rebecca S Stainman1, Zahava Turner, James E Rubenstein

  • 1Department of Neurology and Pediatrics, The John M. Freeman Pediatric Epilepsy Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

Seizure
|June 5, 2007
PubMed

Insights

For children with epilepsy treatable by surgery, the ketogenic diet can reduce seizures. However, surgery offers a higher chance of seizure freedom compared to diet alone.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Research
  • Dietary Therapies

Background:

  • The ketogenic diet is a recognized treatment for intractable childhood epilepsy.
  • Surgery is also a common intervention for surgically approachable epilepsy in children.
  • The comparative efficacy of these two treatment modalities is not fully established.

Purpose of the Study:

  • To compare the efficacy of the ketogenic diet versus surgery in children with surgically approachable epilepsy.
  • To evaluate seizure reduction and freedom rates in pediatric epilepsy patients undergoing different treatment pathways.

Main Methods:

  • Retrospective chart review of 554 children on the ketogenic diet.
  • Comparison of 24 children who underwent resective surgery with 45 matched controls not candidates for surgery.
  • Analysis of seizure frequency, duration on diet, and seizure freedom rates.

Main Results:

  • Children receiving both surgery and the ketogenic diet showed significantly higher seizure reduction (>90%) and seizure freedom rates at 6 months compared to diet alone (71% vs 17% and 63% vs 0%, respectively).
  • The surgical cohort demonstrated a higher likelihood of seizure freedom post-intervention.
  • Non-surgical candidates on the diet had shorter diet adherence durations compared to the surgical group.

Conclusions:

  • While the ketogenic diet is effective in reducing seizures in children with surgically approachable epilepsy, surgery leads to a higher probability of seizure freedom.
  • Surgical intervention should be strongly considered for pediatric epilepsy patients with surgically approachable focal epilepsy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...